Effect of exposition to levodopa/carbidopa (LA/CA) on Machado-Joseph disease/spinocerebellar ataxia type 3 (MJD/SCA3) evolution.
<p>Progress of SARA scores (A) observed in individuals with MJD/SCA3 and (B) predicted by the Linear Mixed Effects model for (top) controls and (bottom) cases of exposition to LA/CA. (B) 95% confidence intervals for 6-year predictions computed assuming a random MJD/SCA3 patient, 58 years of age, and expanded allele length 70. More details in 'Raposo M, Sárkány Z, Damásio J, Consortium CS, Lima M, Macedo-Ribeiro S, et al. Effect of levodopa/carbidopa on the progression of Machado-Joseph disease /spinocerebellar ataxia type 3 (MJD/SCA3). MedRxiv; 2024, doi.org/10.1101/2024.11.28.24318145'.</p>
ShareScore
36/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 4
- Harmonization
- 4
- Access
- 20
- Reuse readiness
- 8
- Engagement
- 0
Dataset details
- Repository
- zenodo
- Published
- November 28, 2024
- License
- cc-by-4.0
- DOI
- 10.5281/zenodo.14244159
Scored with release 0.9.0
ScienceDex for faculty
Your academic CV and NIH biosketch
Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.